FeesSafety
Pluang+

New peptide drugs show promise for weight loss with fewer side effects, entering human trials in 2027

Market News
16 Nov 2026, 14:30 WIB
PRNewsWire
View Source
Bullish
New peptide drugs show promise for weight loss with fewer side effects, entering human trials in 2027

Palatin Technologies announced preclinical success of novel MC4R-selective peptide agonists that reduce body weight and food intake with minimal side effects like hyperpigmentation. Their proprietary lipidation technology enables once-weekly dosing, improving convenience over current daily treatments. The lead candidate, PL2001, is advancing toward first-in-human trials expected in early 2027, targeting rare neuroendocrine obesity disorders. These developments could offer safer, more effective long-term obesity treatments.

Palatin Technologies' new MC4R-selective peptide agonists are highlighted here with Pluang's Health-sector market data as context. For readers following health stocks, as of Nov 16, 2026 18:12 WIB, 66 of 150 priced US Health-sector stocks rose while 50 fell. Notable movers include Centene Corp (CNC) at USD 72.97 with a +2.39% change and a typical hold time of 42 days, Amneal Pharmaceuticals Inc. (AMRX) at USD 20.94 down -2.06% with an 18-day hold, and Dyne Therapeutics Inc. (DYN) at USD 17.50 up +1.98% with a 13-day hold time.

More News

Duke Robotics reports 38% revenue growth in Q3 2026 and expands IC Drone platform to Greece.

Duke Robotics reports 38% revenue growth in Q3 2026 and expands IC Drone platform to Greece.

Duke Robotics announced a 38% year-over-year revenue increase for Q3 2026, driven by its IC Drone insulator-cleaning activities. The company expanded its IC Drone platform into Greece through a strategic collaboration with CRONOS, identifying potenti...

Company Fundamentals
Bullish
44 minutes ago
Newcleo and Curio partner to supply recycled nuclear materials for advanced MOX fuel in US reactors

Newcleo and Curio partner to supply recycled nuclear materials for advanced MOX fuel in US reactors

Newcleo plc and Curio Legacy Ventures announced a collaboration to supply recycled nuclear materials for mixed-oxide (MOX) fuel production at Newcleo's planned US fuel manufacturing facility. This partnership combines Curio's NuCycle recycling techno...

Market News
Bullish
44 minutes ago
Heineken repurchases over 10 million shares in €1.5 billion buyback program's second tranche

Heineken repurchases over 10 million shares in €1.5 billion buyback program's second tranche

Heineken N.V. has repurchased a total of 10,017,690 shares under the second €750 million tranche of its €1.5 billion share buyback program as of November 13, 2026. The shares were bought both on the exchange and from Heineken Holding N.V., with an av...

Company Fundamentals
Neutral
1 hour ago
eGain launches service to prepare enterprise knowledge for reliable AI use without replacing platforms

eGain launches service to prepare enterprise knowledge for reliable AI use without replacing platforms

eGain Corporation introduced the Trusted Knowledge Service, designed to make existing enterprise knowledge AI-ready and reliable without replacing current platforms like SharePoint and Salesforce. The service includes evaluation, preparation, verific...

Market News
Bullish
1 hour ago
eGain launches Trusted Knowledge Service to prepare enterprise data for reliable AI use without platform changes

eGain launches Trusted Knowledge Service to prepare enterprise data for reliable AI use without platform changes

eGain Corporation has introduced the Trusted Knowledge Service, designed to prepare and certify enterprise knowledge for AI use without replacing existing platforms like SharePoint and Salesforce. The service includes assessment, correction, certific...

Market News
Bullish
1 hour ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App